Cohen Amir sold $60K of SRTA
Cohen Amir (Chief Accounting Officer) sold 10,300 shares of Strata Critical Medical, Inc. (SRTA) at $5.79 on 2026-05-21 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The officer sold $59,637 worth of shares via an open-market transaction under a pre-arranged 10b5-1 plan; absent other news, this is more sentiment/positioning than fundamental repricing.
Market read
A disclosed 10b5-1 insider sale can cause short-term noise, but it is usually not a strong standalone trading catalyst.
What to watch
Traders may overreact to the headline; the key is whether there are repeated insider sales or concurrent negative fundamentals not present in this article.
Background
The article is an SEC Form 4 insider transaction disclosure for Strata Critical Medical, Inc. (SRTA).
Ticker impact
Cohen Amir (Chief Accounting Officer) filed an open-market sale of 10,300 SRTA shares at $5.7900 on a 10b5-1 plan.
Likely limited immediate price impact; any reaction should fade unless accompanied by other company-specific catalysts.
The disclosure is an officer transaction under a pre-arranged 10b5-1 plan, with no accompanying operational or financial news in the filing.
Market effects
Minimal—this is a single-company insider transaction with no stated sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a 10b5-1 plan, it may reflect routine liquidity needs rather than negative expectations.
Key entities
- issuerStrata Critical Medical, Inc.
Subject of the SEC Form 4 insider transaction; Chief Accounting Officer sold 10,300 shares at $5.7900.
- insiderCohen Amir
Chief Accounting Officer who executed the sale under a 10b5-1 plan.
